Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TEVA
TEVA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TEVA News
Teva Pharmaceuticals to Release Q2 2026 Financial Results
1d ago
Newsfilter
Teva Pharmaceuticals Transitions to Innovative Drug Development
16h ago
Fool
Teva Pharmaceuticals Reports Strong Q1 Performance
16h ago
NASDAQ.COM
Teva Seeks FDA Approval for Ecopipam in Pediatric Tourette Syndrome
1d ago
seekingalpha
Teva Pharmaceuticals Releases Q2 2026 Aide Memoire
1d ago
Newsfilter
Teva Submits NDA for Ecopipam to Treat Pediatric Tourette Syndrome
1d ago
Newsfilter
Medincell SA Reports Growth Strategy Success with Strong Financials
3d ago
Yahoo Finance
Teva Pharmaceutical's Recovery: Challenges and Opportunities in Biosimilars
Jun 12 2026
Fool
Biotech Sector Sees Surge in FDA and Global Approvals
Jun 12 2026
NASDAQ.COM
Teva Completes Acquisition of Emalex Biosciences for $700 Million
Jun 11 2026
NASDAQ.COM
Teva Acquires Emalex Biosciences to Enhance Pipeline for Tourette Syndrome
Jun 10 2026
Newsfilter
Alvotech's AVT16 Biosimilar Application Accepted by FDA
Jun 08 2026
seekingalpha
Teva Reports New Efficacy Data for Huntington's Disease Treatments
Jun 08 2026
NASDAQ.COM
Alvotech's AVT16 BLA Accepted by FDA for Review
Jun 08 2026
Globenewswire
Survey Reveals Daily Impact of Huntington's Disease Chorea on Patients and Caregivers
Jun 05 2026
Newsfilter
Teva Launches Eylea Biosimilar Ahzantive
Jun 04 2026
Yahoo Finance
Show More News
